AG Sousa

Showing 1-5 of 5 articles

Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis

Costa Jr J, Sousa A, Moreira A, Alves da Costa R, Cano M, Maldonado G, Campos Neto C, Jardim C, Pavanello R, Sousa J

September 30, 2009

Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice

Feres R, Andrade P, Costa R, Costa Jr J, Abizaid A, Staico R, Tanajura L, Siqueira D, Maia J, Lasave L, Sousa A, Sousa J

August 14, 2009

EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

Costa Júnior J, Abizaid A, Feres F, Costa R, Seixas A, Maia F, Abizaid An, Tanajura L, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa A, Fitzgerald P, Sousa J

May 13, 2008

Small coronary arteries treated with sirolimus-eluting stents: one-year results of the PORTO multicentre registry

Seabra-Gomes R, Eduardo Sousa J, Sousa A, Teles R, Pereira H, Farto Abreu P, Adao M, Marques A, Gama Ribeiro V, Mourao L, Santos R, Cyrne Carvalho H

August 20, 2007

The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions

Costa R, Eduardo Sousa J, Abizaid A, Chaves A, Feres F, Sousa A, Musumeci G, Mehran R, Fitzgerald P, Lansky A, Leon M, Shiran A, Halon D, Lewis B, Guagliumi G

November 20, 2006

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease